Improved quantitation of minimal residual disease in multiple myeloma using real-time polymerase chain reaction and plasmid-DNA complementarity determining region III standards

Cancer Research

Volumn 58, Issue 17, 1998, Pages 3957-3964

  Gerard, Christopher J ^a,b   Olsson, Katherine ^a   Ramanathan, Rajeev ^a   Reading, Chris ^a   Hanania, Elie G ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b diaDexus   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; PLASMID DNA;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; MULTIPLE MYELOMA; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE DIAGNOSIS;

BASE SEQUENCE; DNA; HUMANS; MOLECULAR SEQUENCE DATA; MULTIPLE MYELOMA; NEOPLASM, RESIDUAL; PLASMIDS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS;

EID: 0032170539     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Okada, A., and Alt, F. W. The variable gene assembly mechanism. In: T. Honjo and F. W. Alt (eds.), Immunoglobulin Genes, Ed. 2, pp. 205-234. San Diego, CA: Academic Press, 1995.
2. Segal, G. H., Jorgensen, T., Masih, A. S., and Braylan, R. C. Optimal primer selection for clonality assessment by polymerase chain reaction analysis: I. Low grade B-cell lymphoproliferative disorders of nonfollicular center cell type. Hum. Pathol., 25: 1269-1275, 1994.
3. Lemoli, R., Fortuna, A., Motta, M. R., Rizzi, S., Giudice, V., Nannetti, A., Martinelli, G., Cavo, M., Amabile, M., Mangianti, S., Fogli, M., Conte, R., and Tura, S. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells. Blood, 87: 1625-1634, 1996.
4. Lopez, M., Lemoine, F. M., Firat, H., Fouillard, L., Laporte, J. P., Lesage, S., Isnard, F., Stachowiak, J., Ferrer-Le Coeur, F., Morel, P., Najman, A., Douay, L., and Gorin, N. C. Bone marrow versus peripheral blood progenitor cells CD34 selection in patients with non-Hodgkin's lymphomas: different levels of tumor cell reduction. Implications for autografting. Blood, 90: 2830-2838, 1997.
5. Billadeau, D., Blackstadt, M., Greipp, P., Kyle, R. A., Oken, M. M., Kay, N., and Van Ness, B. Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual disease. Blood, 78: 3021-3029, 1991.
6. Billadeau, D., Quam, L., Thomas, W., Kay, N., Greipp, P., Kyle, R., Oken, M. M., and Van Ness, B. Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood, 80: 1818-1824, 1992.
7. Gazitt, Y., Reading, C. C., Hoffman, R., Wickrema, A., Vesole, D. H., Jagannath, S., Condino, J., Lee, B., Barlogie, B., and Tricot, G. Purified CD34+ Lin-Thy+ stem cells do not contain clonal myeloma cells. Blood, 86: 381-389, 1995.
8. Jonsson, O. G., Kitchens, R. L., Scott, F. C., and Smith, R. G. Detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin hypervariable region specific oligonucleotide probes. Blood, 76: 2072-2079, 1990.
9. Scholten, C., Hilgarth, B., Hilgarth, M., Jaeger, U., Greinix, H. T., and Mannhalter, C. Predictive value of clone-specific CDR3 PCR in high-grade non-Hodgkin's lymphoma: long-term persistence of a clone-specific rearrangement in a patient with secondary high-grade NHL in remission after high-dose therapy. Br. J. Haematol., 97: 239-247, 1997.
10. H, genes of human immunoglobulin heavy chains are encoded in 9-kilobase DNA fragments. Eur. J. Immunol., 18: 649-652, 1988.
11. Southern, E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol., 98: 503-517, 1975.
12. Yamada, M., Hudson, S., Tournay, O., Bittenbender, S., Shane, S. S., Lange, B., Tsujimoto, Y., Caton, A. J., and Rovera, G. Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes. Proc. Natl. Acad. Sci. USA, 86: 5123-5127, 1989.
13. Bersagel, P. L., Smith, A. M., Szczepek, A., Mant, M. J., Belch, A. R., and Pilarski, L. M. In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain. Blood, 85: 436-447, 1995.
14. Willems, P., Croockewit, A., Raymakers, R., Holdrinet, R., Van Der Bosch, G., Huys, E., and Mensink, E. CD34 selections from myeloma peripheral blood cell autografts contain residual tumour cells due to impurity, not to CD34+ myeloma cells. Br. J. Haematol., 93: 613-622, 1996.
15. Zwicky, C. S., Maddocks, A. B., Andersen, N., and Gribben, J. G. Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplantation. Blood, 88: 3314-3322, 1996.
16. Miller, R. G. Regression Techniques. In: Simultaneous Statistical Inference, Ed. 2, Ch. 3, pp. 109-128. New York: Springer-Verlag, 1981.
17. Schiller, G., Vescio, R., Freytes, C., Spitzer, G., Sahebi, F., Lee, M., Wu, C. H., Cao, J., Lee, J. C., Hong, C. H., Lichtenstein, A., Lill, M., Hall, J., Berenson, R., and Berenson, J. Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood, 56: 390-397, 1995.
18. Henry, J. M., Sykes, P. J., Brisco, M. J., To, L. B., and Juttner, C. A. Comparison of myeloma cell contamination of bone marrow and peripheral blood stem cell harvests. Br. J. Haematol., 92: 614-619, 1996.
19. Holland, P. M., Abramson, R. D., Watson, R., and Gelfand, D. H. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Theremus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. USA, 88: 7276-7280, 1991.
20. Lee, L. G., Connell, C. R., and Bloch, W. Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res., 21: 3761-3766, 1993.
21. Förster, V. T. Zwischenmolekulare Energiewanderung und Fluoreszenz. Ann. Physics, 2: 55-75, 1948.
22. Livak, K. J., Flood, S. J. A., Marmaro, J., Giusti, W., and Deetz, K. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl., 4: 357-362, 1995.
23. Bassler, H. A., Flood, S. J. A., Livak, K. J., Marmaro, J., Knorr, R., and Batt, C. A. Use of a fluorogenic probe in a PCR-based assay for the detection of Listeria monocytogenes. Appl. Environ. Microbiol., 61: 3724-3728, 1995.
24. Gerard, C. J., Arboleda, M. J., Solar, G., Mulé, J. J., and Kerr, W. G. A rapid and quantitative assay to estimate gene transfer into retrovirally transduced hematopoietic stem/progenitor cells using a 96-well format PCR and fluorescent detection system universal for MMLV-based proviruses. Hum. Gene Ther., 7: 343-354, 1996.
25. Witham, P. K., Yamashiro, C. T., Livak, K. J., and Batt, C. A. A PCR-based assay for the detection of Escherichia coli shiga-like toxin genes in ground beef. Appl. Environ. Microbiol., 62: 1347-1353, 1996.
26. Heid, C. A., Stevens, J., Livak, K. J., and Williams, P. M. Real time quantitative PCR. Genome Res., 6: 986-994, 1996.
27. Gibson, U. E. M., Heid, C. A., and Williams, P. M. A novel method for real time quantitative RT-PCR. Genome Res., 6: 995-1001, 1996.
28. Dawson-Saunder, B., and Trapp, R. G. Statistical methods for multiple variables. In: Basic, and Clinical Biostatistics, Ch. 12, pp. 207-228. Norwalk, CT: Appleton and Lange, 1990.
29. Watkins, B. A., Davis, A. E., Fiorentini, S., and Reitz, M. S., Jr. V-region and class specific RT-PCR amplification of human immunoglobulin heavy and light chain genes from B-cell lines. Scand. J. Immunol., 42: 442-448, 1995.
30. McGill, R., Tukey, J. W., and Larsen, W. A. Variations of box plots. Am. Stat., 32: 12-16, 1978.
31. Fermand, J. P., Chevret, S., Ravaud, P., Divine, M., Leblond, V., Dreyfus, F., Mariette, X., and Brouet, J. C. High-dose chemotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients. Blood, 7: 2005-2010, 1993.
32. Dreyfus, F., Leblond V., Ravaud, P., Melle, J., Quarre, M. C., Pillier, C., Boccaccio, C., and Varet, B. Detection of malignant B cells in peripheral blood stem cell collections after chemotherapy in patients with multiple myeloma. Bone Marrow Transplant., 15: 707-711, 1995.
33. Bjorkstrand, B. Multiple myeloma, high-dose treatment and autologous stem cell transplantation: current status. Med. Oncol., 13: 23-30, 1996.
34. Gribben, J. G., Neuberg, D., Barber, M., Moore, J., Pesek, K. W., Freedman, A. S., and Nadler, L. M. Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood, 83: 3800-3807, 1994.
35. Brenner, M. K. Gene Marking. Hum. Gene Ther., 7: 1927-1936, 1996.
36. Gribben, J. G., Neuberg, D., Freedman, A. S., Gimmi, C. D., Pesek, K. W., Barber, M., Saporito, L., Woo, S. D., Coral, F., Spector, N., Rabinowe, S. N., Grossbard, M. L., Ritz, J., and Nadler, L. M. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood, 81: 3449-3457, 1993.
37. Hartley, J. L., and Rashtchian, A. Dealing with contamination: enzymatic control of carry-over contamination in PCR. PCR Methods Appl., 3: S10-S14, 1993.
38. Corradini, P., Astolfi, M., Cherasco, C., Ladetto, M., Voena, C., Caracciolo, D., Pileri, A., and Tarella, C. Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting. Blood, 89: 724-731, 1997.
39. Gribben, J. G., Freedman, A. S., Neuberg, D., Roy, D. C., Blake, K. W., Woo, S. D., Grossbard, M. L., Rabinowe, S. N., Coral, F., Freeman, G. J., Ritz, J., and Nadler, L. M. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N. Engl. J. Med., 325: 1525-1533, 1991.
40. Negrin, R. S., Kiem, H-P., Schmidt-Wolf, I. G. H., Blume, K. G., and Cleary, M. L. Use of the polymerase chain reaction to monitor the effectiveness of ex vivo tumor cell purging. Blood, 77: 654-660, 1991.
41. Billadeau, D., Prosper, F., Verfaillie, C., Wesdorf, D., and Van Ness, B. Sequential analysis of bone marrow and peripheral blood after stem cell transplant for myeloma shows disparate tumor involvement. Leukemia (Baltimore), 11: 1565-1570, 1997.